.webp)
Key takeaways:
- Referring a patient takes about two minutes via the online form or fax, and links the patient to your practice.
- Referred patients are nearly four times more likely to start Nerva, and more likely to complete it, than those who self-refer.¹
- Older patients are among the most engaged and highest-responding users, so age is no reason to hold back a referral to a digital program.²
A simple get-started guide to share with patients
Download this short, step-by-step guide to share with patients you refer to Nerva – print it, email it, or hand it over in clinic.
DOWNLOAD: Nerva get-started guide for referred patients (PDF)
Give patients more than a recommendation: why a documented referral from you drives better outcomes
When you tell a patient to just Google Nerva, look into it themselves, or say you've heard it's worth a try, they self-navigate and you lose sight of them. No progress reports come back to you, so your next appointment starts from scratch.
A documented referral changes that. It triggers the patient's setup email, links them to your practice, and applies the correct pricing automatically: a 25% provider-referred discount for all referred patients, with no cost for eligible US patients aged 65 and older – savings self-navigators miss.
It also sends you progress reports on the patients you refer, so you can see how they are tracking and make your follow-up appointments far more useful. And if cost is a barrier for a patient, the same form lets you nominate them for our Patient Assistance Program (PAP). US patients can also put HSA or FSA funds toward Nerva to bring the cost down further.
Your team can reach real support at healthcare@nervahealth.com if you ever need a hand.
Is digital gut-directed hypnotherapy suitable for older patients?
Older patients do as well as younger ones with digital gut-directed hypnotherapy, and often better.²
Clinicians often assume a digital program suits younger patients more, but the real-world data points the other way.
In a real-world analysis of 131,900 users, 61% of patients aged 65 to 74 completed the program, among the highest of any age group, and older users were more likely to achieve a meaningful reduction in abdominal pain.² For many older patients, a low-risk, drug-free option that sidesteps polypharmacy is especially welcome.
This means age is a reason to refer, not to hold back.
Refer your next patient in two minutes
Refer through the online form or by fax to +1 212-377-0271, and send them the get-started guide (PDF) at the same time so they know exactly what to do next.
It takes about two minutes and sets your patient up with the right pricing, support, and progress reports back to you.
Bookmark the form now, so it is ready the moment your next patient could benefit.
Frequently asked questions
How do I refer a patient to Nerva?
Complete the online provider referral form or send a fax to +1 212-377-0271. It takes less than 2 minutes and triggers the patient's setup email and referred pricing.
Is the referral form secure?
The referral form is secure and HIPAA-compliant. Patient details are encrypted and handled to strict healthcare privacy and security standards, so you can refer with confidence.
How long is the program, and what is the time commitment?
Nerva's core program runs six weeks, in daily 15-to-20-minute sessions, and form-referred patients get a full 12 months of access to revisit sessions for ongoing maintenance. Adherence in those first six weeks is the main predictor of response, so it helps to set that expectation at referral.
References
Mindset Health internal analysis (Nerva), all users to date.
Hall C, Dabash O, Peters SL. Older adults with IBS demonstrate higher engagement and improved abdominal pain outcomes with digital gut-directed hypnotherapy: real-world analysis of 131,900 enrolled users [Poster]. Australian Gastroenterology Week (AGW), 2026.
Anderson EJ, Peters SL, Gibson PR, Halmos EP. Comparison of a digitally delivered gut-directed hypnotherapy program with an active control for irritable bowel syndrome. Am J Gastroenterol. 2025;120(2):440-448.
